Clinical Approaches to Diagnosing Infectious and Autoimmune Encephalitis

Brain inflammation secondary to encephalitis has been identified as an urgent global emergency. According to a seminar published by The Lancet on May 16, 2026, addressing this condition presents multiple opportunities to reduce current levels of substantial morbidity and mortality.

The causes of this inflammation, referred to as aetiologies, are divided into two primary categories: infectious causes and autoimmune causes.

Diagnostic Approaches and Identification

Effective management of the condition relies on the ability to recognize and distinguish between different triggers. The seminar highlights the importance of using pragmatic clinical approaches to differentiate the most common pathogenic viruses from an emerging range of autoantibodies encountered in routine medical practice.

The diagnostic process begins with pre-test impressions, which are then judiciously shaped by the use of simple, valuable investigations.

To identify the precise causative agent of the brain inflammation, medical practitioners utilize specific testing on two primary biological samples:

• Serum
• Cerebrospinal fluid

Within these samples, the identification of the causative agent is achieved through nucleic acid and autoantibody testing.